Trial Profile
The Effect of Exenatide on Insulin Requirement, Weight and Inflammation in Obese Type 2 Diabetic Subjects on Insulin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Oct 2022
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 14 Dec 2012 Actual end date Nov 2011 added as reported by ClinicalTrials.gov.
- 05 Jun 2012 Planned End Date changed from 1 May 2011 to 1 May 2013 as reported by ClinicalTrials.gov record.
- 12 Jul 2010 New trial record